Neuralink's First Human Patient: Progress and Implications

The boundary between human biology and digital technology blurred significantly in early 2024 when Neuralink, the neurotechnology company founded by Elon Musk, successfully implanted its brain-computer interface (BCI) into a human for the first time. This event marked a critical step in the PRIME Study, a trial designed to evaluate the safety and functionality of the implant. For the millions of people living with paralysis, the progress reported by this first patient offers a tangible look at how BCI technology might restore independence.

Noland Arbaugh: The First Pioneer

The first human to receive the Neuralink N1 implant is Noland Arbaugh, a 29-year-old Arizona resident who became quadriplegic following a diving accident in 2016. Before the surgery, Arbaugh relied on a mouth stick (a stylus held in the mouth) to interact with tablet computers. This method was functional but limiting, causing fatigue and restricting his ability to speak while working or playing.

In January 2024, Arbaugh underwent surgery at the Barrow Neurological Institute in Phoenix. The procedure involved the R1 Robot surgically placing the N1 implant in a region of the brain that controls movement intention.

Initial Capabilities and Milestones

The results were immediate and transformative. Within days of the activation, Arbaugh was able to control a computer cursor using only his thoughts. Key milestones included:

  • Gaming: Arbaugh successfully played complex video games, including Civilization VI and Mario Kart 8 Deluxe. He famously stayed up until 6:00 AM playing Civilization VI immediately after gaining the ability, something he had been unable to do independently for years.
  • Chess: He demonstrated the ability to play online chess with high speed and precision, multitasking while talking to researchers.
  • Web Navigation: The implant allowed for seamless browsing, scrolling, and clicking, enabling him to manage emails and study Japanese without physical assistance.

Technical Challenges: The Retraction Issue

The road to progress was not without mechanical bumps. In the weeks following the surgery, Neuralink engineers noticed a decrease in the data throughput (measured in bits per second, or BPS). The team discovered that several of the implant’s “threads”—hair-thin wires containing electrodes—had retracted from the brain tissue.

This retraction meant fewer electrodes were recording neural spikes, which made the cursor control less accurate. In response, Neuralink did not require a second surgery. Instead, they modified the recording algorithm.

The Software Fix:

  • The system was updated to be more sensitive to neural population signals rather than just individual neuron spikes.
  • Engineers improved the techniques for translating these signals into cursor movements.

Following these software updates, Arbaugh’s performance not only recovered but eventually surpassed his initial records. This demonstrated a crucial advantage of the system: the ability to improve functionality through over-the-air software updates rather than invasive hardware replacements.

The Second Patient: Validating the Progress

To prove that Arbaugh’s success was not a fluke, Neuralink implanted a second participant, identified as “Alex,” in August 2024. Learning from the first surgery, the medical team took measures to prevent the thread retraction issue, such as reducing the gap between the implant and the brain surface.

Alex’s progress has further validated the technology. He has used the implant to use CAD (Computer-Aided Design) software to design a 3D mount for his Neuralink charger, which was then 3D printed. He has also been able to play first-person shooter games like Counter-Strike 2, utilizing the implant for aiming while using a separate mouth controller for movement.

Future Medical Applications

While current applications focus on digital control for entertainment and communication, the long-term medical implications of the PRIME Study are vast. The N1 implant is designed to be a platform that can be expanded for various neurological conditions.

Restoring Motor Function

The immediate goal is to refine the cursor control to match the speed of an able-bodied user. However, the next major phase involves physical output. Neuralink aims to bypass damaged spinal cords by transmitting signals from the brain implant directly to a second implant on the spine or muscles. This could theoretically restore movement to paralyzed limbs.

Blindsight

Elon Musk has publicly discussed a future product named “Blindsight.” This application would target the visual cortex. Even if a person has lost their eyes or optic nerve, direct stimulation of the visual cortex could potentially restore a form of vision. The resolution would likely be low initially, similar to early 8-bit graphics, but could improve as electrode density increases.

Mental Health and Neurology

Beyond motor and sensory restoration, deep brain stimulation (DBS) is already a known treatment for conditions like Parkinson’s disease. Advanced BCIs could offer more precise, responsive treatments for:

  • Epilepsy (predicting and stopping seizures).
  • Severe depression.
  • Memory loss associated with Alzheimer’s.

How the Technology Works

Understanding the progress requires looking at the hardware itself. The N1 Implant is roughly the size of a coin. It is hermetically sealed and biocompatible.

  • Electrodes: The device features 1,024 electrodes distributed across 64 threads. These threads are so flexible and thin that a human hand cannot insert them; the R1 Robot is required to insert them to avoid damaging blood vessels.
  • Wireless Data: Unlike older BCI iterations that required a port in the skull and wires tethered to a server, the N1 transmits data wirelessly to an app on a computer or phone.
  • Charging: The battery is charged wirelessly from the outside using an inductive charger, typically worn in a specialized cap or pillow.

Frequently Asked Questions

Is the Neuralink implant available to the public? No. The device is currently in the clinical trial phase (the PRIME Study) authorized by the FDA. It is only available to a select few participants who meet specific criteria regarding quadriplegia and spinal cord injury. Commercial availability is likely years away.

Can the implant be removed or upgraded? Yes. Neuralink designed the N1 to be upgradeable. Because technology moves faster than biology, the company anticipates that users will want newer models with better battery life and higher channel counts. The surgical procedures are designed to allow for explantation and replacement.

Does the surgery hurt? The brain itself has no pain receptors. The surgery is performed under anesthesia, but the patient does not feel the threads being inserted. Noland Arbaugh reported that the surgery was “super easy” and he was released from the hospital the following day.

How does this differ from previous BCIs? Traditional BCIs, like the Utah Array, are rigid and can cause scarring in the brain tissue over time. They also typically require a wire protruding from the head. Neuralink’s primary differentiators are the flexibility of the threads (minimizing damage), the high number of electrodes (1,024 vs. the typical 100), and the fully wireless design.